{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:56:44Z","timestamp":1774846604706,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,29]]},"DOI":"10.7759\/cureus.106088","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:23:14Z","timestamp":1774840994000},"source":"Crossref","is-referenced-by-count":0,"title":["Single Antiplatelet Therapy With Ticagrelor in Flow-Diversion Treatment of Ruptured Dissecting Cerebral Pseudoaneurysms: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Saeed A","family":"Alqahtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"AlQahatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13120099","article-title":"Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial","volume":"267","author":"Becske T","year":"2013","unstructured":"Becske T, Kallmes DF, Saatci I, et al.. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013, 267:858-68. 10.1148\/radiol.13120099","journal-title":"Radiology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000339109.98070.65","article-title":"Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience","volume":"64","author":"Lylyk P","year":"2009","unstructured":"Lylyk P, Miranda C, Ceratto R, et al.. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery. 2009, 64:632-43. 10.1227\/01.NEU.0000339109.98070.65","journal-title":"Neurosurgery"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.620328","article-title":"Flow diversion for intracranial aneurysms: a review","volume":"42","author":"D'Urso PI","year":"2011","unstructured":"D'Urso PI, Lanzino G, Cloft HJ, Kallmes DF. Flow diversion for intracranial aneurysms: a review. Stroke. 2011, 42:2363-8. 10.1161\/STROKEAHA.111.620328","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2907","article-title":"Flow-diverter silk stent for the treatment of intracranial aneurysms: 1-year follow-up in a multicenter study","volume":"33","author":"Berge J","year":"2012","unstructured":"Berge J, Biondi A, Machi P, et al.. Flow-diverter silk stent for the treatment of intracranial aneurysms: 1-year follow-up in a multicenter study. AJNR Am J Neuroradiol. 2012, 33:1150-5. 10.3174\/ajnr.A2907","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyz391","article-title":"Antiplatelet therapy in flow diversion","volume":"86","author":"Tonetti DA","year":"2020","unstructured":"Tonetti DA, Jankowitz BT, Gross BA. Antiplatelet therapy in flow diversion. Neurosurgery. 2020, 86:47-52. 10.1093\/neuros\/nyz391","journal-title":"Neurosurgery"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-012-1047-3","article-title":"Italian multicenter experience with flow-diverter devices for intracranial unruptured aneurysm treatment with periprocedural complications - a retrospective data analysis","volume":"54","author":"Briganti F","year":"2012","unstructured":"Briganti F, Napoli M, Tortora F, et al.. Italian multicenter experience with flow-diverter devices for intracranial unruptured aneurysm treatment with periprocedural complications - a retrospective data analysis. Neuroradiology. 2012, 54:1145-52. 10.1007\/s00234-012-1047-3","journal-title":"Neuroradiology"},{"key":"ref7","article-title":"Plasticity of motor representations in patients with brain lesions: a navigated TMS study","volume":"126","author":"Krieg S","year":"2017","unstructured":"Krieg S, Bulubas L, Sollmann N, Tanigawa N, Meyer B. Plasticity of motor representations in patients with brain lesions: a navigated TMS study. J Neurosurg Spine. 2017, 126:","journal-title":"J Neurosurg Spine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.925115","article-title":"Anterior circulation fusiform aneurysms have a lower occlusion rate after pipeline embolization device treatment than posterior circulation fusiform aneurysms: a multicenter cohort study","volume":"13","author":"Xu C","year":"2022","unstructured":"Xu C, Wu P, Zou L, Xu S, Luo B, Yang X, Shi H. Anterior circulation fusiform aneurysms have a lower occlusion rate after pipeline embolization device treatment than posterior circulation fusiform aneurysms: a multicenter cohort study. Front Neurol. 2022, 13:10.3389\/fneur.2022.925115","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy002","article-title":"Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms","volume":"84","author":"Narata AP","year":"2019","unstructured":"Narata AP, Amelot A, Bibi R, Herbreteau D, Angoulvant D, Gruel Y, Janot K. Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms. Neurosurgery. 2019, 84:77-83. 10.1093\/neuros\/nyy002","journal-title":"Neurosurgery"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/15910199231168669","article-title":"The safety profile of single antiplatelet therapy with flow diverters: systematic review and meta-analysis","author":"Senol YC","year":"2023","unstructured":"Senol YC, Orscelik A, Ghozy S, et al.. The safety profile of single antiplatelet therapy with flow diverters: systematic review and meta-analysis. Interv Neuroradiol. 2023, 10.1177\/15910199231168669","journal-title":"Interv Neuroradiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac116","article-title":"P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications","volume":"43","author":"Turgeon RD","year":"2022","unstructured":"Turgeon RD, Koshman SL, Dong Y, Graham MM. P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications. Eur Heart J. 2022, 43:2303-13. 10.1093\/eurheartj\/ehac116","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe H","year":"2019","unstructured":"Watanabe H, Domei T, Morimoto T, et al.. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial. JAMA. 2019, 321:2414-27. 10.1001\/jama.2019.8145","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140804","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: a review of the evidence","volume":"72","author":"Davis KA","year":"2015","unstructured":"Davis KA, Miyares MA, Dietrich E. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: a review of the evidence. Am J Health Syst Pharm. 2015, 72:1623-9. 10.2146\/ajhp140804","journal-title":"Am J Health Syst Pharm"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.11.065","article-title":"Single-antiplatelet therapy in patients with contraindication to dual-antiplatelet therapy after transcatheter aortic valve implantation","volume":"119","author":"Mangieri A","year":"2017","unstructured":"Mangieri A, Jabbour RJ, Montalto C, et al.. Single-antiplatelet therapy in patients with contraindication to dual-antiplatelet therapy after transcatheter aortic valve implantation. Am J Cardiol. 2017, 119:1088-93. 10.1016\/j.amjcard.2016.11.065","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1550-9","article-title":"Single versus dual anti-platelet therapy post transcatheter aortic valve implantation: a meta-analysis of randomized controlled trials","volume":"44","author":"Ando T","year":"2017","unstructured":"Ando T, Takagi H, Briasoulis A, Afonso L. Single versus dual anti-platelet therapy post transcatheter aortic valve implantation: a meta-analysis of randomized controlled trials. J Thromb Thrombolysis. 2017, 44:448-56. 10.1007\/s11239-017-1550-9","journal-title":"J Thromb Thrombolysis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13429","article-title":"Effects of P2Y12 receptor antagonists beyond platelet inhibition - comparison of ticagrelor with thienopyridines","volume":"173","author":"Nylander S","year":"2016","unstructured":"Nylander S, Schulz R. Effects of P2Y12 receptor antagonists beyond platelet inhibition - comparison of ticagrelor with thienopyridines. Br J Pharmacol. 2016, 173:1163-78. 10.1111\/bph.13429","journal-title":"Br J Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.100","article-title":"Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (Platelet inhibition and patient Outcomes) PLATELET substudy","volume":"56","author":"Storey RF","year":"2010","unstructured":"Storey RF, Angiolillo DJ, Patil SB, et al.. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (Platelet inhibition and patient Outcomes) PLATELET substudy. J Am Coll Cardiol. 2010, 56:1456-62. 10.1016\/j.jacc.2010.03.100","journal-title":"J Am Coll Cardiol"},{"key":"ref18","article-title":"Comparison of ticagrelor and high-dose clopidogrel on the platelet functions in patients with inadequate response to clopidogrel","volume":"7","author":"Gu X","year":"2017","unstructured":"Gu X, Fu X, Wang Y, et al.. Comparison of ticagrelor and high-dose clopidogrel on the platelet functions in patients with inadequate response to clopidogrel. Am J Cardiovasc Dis. 2017, 7:1-8.","journal-title":"Am J Cardiovasc Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.002816","article-title":"Clopidogrel versus aspirin as an antiplatelet monotherapy after 12-month dual-antiplatelet therapy in the era of drug-eluting stents","volume":"9","author":"Park TK","year":"2016","unstructured":"Park TK, Song YB, Ahn J, et al.. Clopidogrel versus aspirin as an antiplatelet monotherapy after 12-month dual-antiplatelet therapy in the era of drug-eluting stents. Circ Cardiovasc Interv. 2016, 9:10.1161\/CIRCINTERVENTIONS.115.002816","journal-title":"Circ Cardiovasc Interv"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.026044","article-title":"Comparative effectiveness of dual antiplatelet therapy with aspirin and clopidogrel versus aspirin monotherapy in acute, nonminor stroke: a nationwide, multicenter registry-based study","volume":"50","author":"Kim JT","year":"2019","unstructured":"Kim JT, Park MS, Choi KH, et al.. Comparative effectiveness of dual antiplatelet therapy with aspirin and clopidogrel versus aspirin monotherapy in acute, nonminor stroke: a nationwide, multicenter registry-based study. Stroke. 2019, 50:3147-55. 10.1161\/STROKEAHA.119.026044","journal-title":"Stroke"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht438","article-title":"Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome","volume":"35","author":"Varenhorst C","year":"2014","unstructured":"Varenhorst C, Jensevik K, Jernberg T, et al.. Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome. Eur Heart J. 2014, 35:969-78. 10.1093\/eurheartj\/eht438","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.002590","article-title":"Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis","volume":"45","author":"Gouya G","year":"2014","unstructured":"Gouya G, Arrich J, Wolzt M, et al.. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. Stroke. 2014, 45:492-503. 10.1161\/STROKEAHA.113.002590","journal-title":"Stroke"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet inhibition and patient Outcomes (PLATO) trial","volume":"124","author":"Mahaffey KW","year":"2011","unstructured":"Mahaffey KW, Wojdyla DM, Carroll K, et al.. Ticagrelor compared with clopidogrel by geographic region in the Platelet inhibition and patient Outcomes (PLATO) trial. Circulation. 2011, 124:544-54. 10.1161\/CIRCULATIONAHA.111.047498","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/15910199231177745","article-title":"Single antiplatelet regimen in flow diverter treatment of cerebral aneurysms: the drug matters. A systematic review and meta-analysis","author":"Ma Y","year":"2023","unstructured":"Ma Y, Madjidyar J, Schubert T, Thurner P, Barnaure I, Kulcsar Z. Single antiplatelet regimen in flow diverter treatment of cerebral aneurysms: the drug matters. A systematic review and meta-analysis. Interv Neuroradiol. 2023, 10.1177\/15910199231177745","journal-title":"Interv Neuroradiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher D","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al.. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015, 4:10.1186\/2046-4053-4-1","journal-title":"Syst Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009, 339:10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments","volume":"14","author":"Lo CK","year":"2014","unstructured":"Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014, 14:10.1186\/1471-2288-14-45","journal-title":"BMC Med Res Methodol"},{"key":"ref28","unstructured":"Statistical algorithms in Review Manager 5. (2007). https.\/\/www.researchgate.net\/publication\/252093205_Statistical_Algorithms_in_Review_Manager_5."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurad.2022.11.010","article-title":"Ticagrelor versus clopidogrel dual antiplatelet therapy for unruptured intracranial aneurysms treated with flowdiverter","volume":"50","author":"Papaxanthos J","year":"2023","unstructured":"Papaxanthos J, Cagnazzo F, Collemiche FL, et al.. Ticagrelor versus clopidogrel dual antiplatelet therapy for unruptured intracranial aneurysms treated with flowdiverter. J Neuroradiol. 2023, 50:346-51. 10.1016\/j.neurad.2022.11.010","journal-title":"J Neuroradiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-015978","article-title":"Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the pipeline embolization device (PED): multicenter experience","volume":"12","author":"Mohammaden MH","year":"2020","unstructured":"Mohammaden MH, English SW, Stapleton CJ, Khedr E, Shoyb A, Hegazy A, Elbassiouny A. Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the pipeline embolization device (PED): multicenter experience. J Neurointerv Surg. 2020, 12:1113-6. 10.1136\/neurintsurg-2020-015978","journal-title":"J Neurointerv Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.708411","article-title":"Early treatment of ruptured blood blister-like aneurysms of the internal carotid artery with flow diverters using single antiplatelet therapy: a single-center experience with long-term follow-up","volume":"12","author":"Tanburoglu A","year":"2021","unstructured":"Tanburoglu A, Andic C. Early treatment of ruptured blood blister-like aneurysms of the internal carotid artery with flow diverters using single antiplatelet therapy: a single-center experience with long-term follow-up. Front Neurol. 2021, 12:10.3389\/fneur.2021.708411","journal-title":"Front Neurol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7216","article-title":"Ticagrelor versus clopidogrel in the dual antiplatelet regimen for intracranial stenting or flow-diverter treatment for unruptured cerebral aneurysms: a single-center cohort study","volume":"42","author":"Park KY","year":"2021","unstructured":"Park KY, Ozaki T, Kostynskyy A, et al.. Ticagrelor versus clopidogrel in the dual antiplatelet regimen for intracranial stenting or flow-diverter treatment for unruptured cerebral aneurysms: a single-center cohort study. AJNR Am J Neuroradiol. 2021, 42:1638-44. 10.3174\/ajnr.A7216","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyx079","article-title":"A multicenter cohort comparison study of the safety, efficacy, and cost of ticagrelor compared to clopidogrel in aneurysm flow diverter procedures","volume":"81","author":"Moore JM","year":"2017","unstructured":"Moore JM, Adeeb N, Shallwani H, et al.. A multicenter cohort comparison study of the safety, efficacy, and cost of ticagrelor compared to clopidogrel in aneurysm flow diverter procedures. Neurosurgery. 2017, 81:665-71. 10.1093\/neuros\/nyx079","journal-title":"Neurosurgery"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-023-01749-7","article-title":"Multicenter comparison of the safety and efficacy of clopidogrel versus ticagrelor for neuroendovascular stents","volume":"40","author":"May CC","year":"2024","unstructured":"May CC, Holden D, Robbins BT, et al.. Multicenter comparison of the safety and efficacy of clopidogrel versus ticagrelor for neuroendovascular stents. Neurocrit Care. 2024, 40:262-71. 10.1007\/s12028-023-01749-7","journal-title":"Neurocrit Care"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-011-0949-9","article-title":"Treatment of intracranial aneurysms. Reconstruction of the parent artery with flow-diverting (Silk) stent","volume":"54","author":"Wagner A","year":"2012","unstructured":"Wagner A, Cortsen M, Hauerberg J, Romner B, Wagner MP. Treatment of intracranial aneurysms. Reconstruction of the parent artery with flow-diverting (Silk) stent. Neuroradiology. 2012, 54:709-18. 10.1007\/s00234-011-0949-9","journal-title":"Neuroradiology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0609","article-title":"Flow diversion for the treatment of intracranial aneurysms","volume":"73","author":"Walcott BP","year":"2016","unstructured":"Walcott BP, Stapleton CJ, Choudhri O, Patel AB. Flow diversion for the treatment of intracranial aneurysms. JAMA Neurol. 2016, 73:1002-8. 10.1001\/jamaneurol.2016.0609","journal-title":"JAMA Neurol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0000000000000522","article-title":"Flow-diverting stents for intracranial bifurcation aneurysm treatment","volume":"75","author":"Saleme S","year":"2014","unstructured":"Saleme S, Iosif C, Ponomarjova S, et al.. Flow-diverting stents for intracranial bifurcation aneurysm treatment. Neurosurgery. 2014, 75:623-31. 10.1227\/NEU.0000000000000522","journal-title":"Neurosurgery"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2024.01.028","article-title":"A study on the efficacy and safety of pipeline shield stents and nonmodified surface flow-diverting stents in patients with intracranial aneurysms","volume":"183","author":"Garc\u00eda-N\u00fa\u00f1ez J","year":"2024","unstructured":"Garc\u00eda-N\u00fa\u00f1ez J, Vera DD, Ortiz AF, et al.. A study on the efficacy and safety of pipeline shield stents and nonmodified surface flow-diverting stents in patients with intracranial aneurysms. World Neurosurg. 2024, 183:781-6. 10.1016\/j.wneu.2024.01.028","journal-title":"World Neurosurg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-SNIS.266","article-title":"E-235 Use of 45 mg twice daily ticagrelor with 81 mg aspirin for endovascular treatment of unruptured intracranial aneurysms: a single center experience","author":"Mehta T","year":"2020","unstructured":"Mehta T, Masood K, Ghannnam M, Grande A, Tummala R, Jagadeesan B. E-235 Use of 45 mg twice daily ticagrelor with 81 mg aspirin for endovascular treatment of unruptured intracranial aneurysms: a single center experience. 2020. 10.1136\/neurintsurg-2020-SNIS.266"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.678151","article-title":"Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis","volume":"44","author":"Brinjikji W","year":"2013","unstructured":"Brinjikji W, Murad MH, Lanzino G, Cloft HJ, Kallmes DF. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke. 2013, 44:442-7. 10.1161\/STROKEAHA.112.678151","journal-title":"Stroke"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/15910199211054959","article-title":"Ticagrelor versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms","volume":"28","author":"Chien SC","year":"2022","unstructured":"Chien SC, Chen CC, Chen CT, et al.. Ticagrelor versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms. Interv Neuroradiol. 2022, 28:568-74. 10.1177\/15910199211054959","journal-title":"Interv Neuroradiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2023.06.063","article-title":"Comparison of clopidogrel and ticagrelor for dual antiplatelet therapy of patients with unruptured cerebral aneurysms undergoing endovascular treatment","volume":"177","author":"Hurtado-Ortiz KD","year":"2023","unstructured":"Hurtado-Ortiz KD, Ortiz-Giraldo AF, Vera-Camargo D, et al.. Comparison of clopidogrel and ticagrelor for dual antiplatelet therapy of patients with unruptured cerebral aneurysms undergoing endovascular treatment. World Neurosurg. 2023, 177:408-14. 10.1016\/j.wneu.2023.06.063","journal-title":"World Neurosurg"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1177\/19714009211049086","article-title":"Determinants of intracranial aneurysm retreatment following embolization with a single flow-diverting stent","volume":"35","author":"Vranic JE","year":"2022","unstructured":"Vranic JE, Harker P, Stapleton CJ, et al.. Determinants of intracranial aneurysm retreatment following embolization with a single flow-diverting stent. Neuroradiol J. 2022, 35:461-7. 10.1177\/19714009211049086","journal-title":"Neuroradiol J"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt DL","year":"2006","unstructured":"Bhatt DL, Fox KA, Hacke W, et al.. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006, 354:1706-17. 10.1056\/NEJMoa060989","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca MP","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, et al.. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015, 372:1791-800. 10.1056\/NEJMoa1500857","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin L","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, et al.. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009, 361:1045-57. 10.1056\/NEJMoa0904327","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.757303","article-title":"Ticagrelor: the first novel reversible P2Y12 inhibitor","volume":"14","author":"Htun WW","year":"2013","unstructured":"Htun WW, Steinhubl SR. Ticagrelor: the first novel reversible P2Y12 inhibitor. Expert Opin Pharmacother. 2013, 14:237-45. 10.1517\/14656566.2013.757303","journal-title":"Expert Opin Pharmacother"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.124248","article-title":"Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study","volume":"127","author":"Kohli P","year":"2013","unstructured":"Kohli P, Wallentin L, Reyes E, et al.. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Circulation. 2013, 127:673-80. 10.1161\/CIRCULATIONAHA.112.124248","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177872","article-title":"The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: a systematic review and meta-analysis","volume":"12","author":"Tan Q","year":"2017","unstructured":"Tan Q, Jiang X, Huang S, et al.. The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: a systematic review and meta-analysis. PLoS One. 2017, 12:10.1371\/journal.pone.0177872","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2022-019361","article-title":"Single-antiplatelet regimen in ruptured cerebral blood blister and dissecting aneurysms treated with flow-diverter stent reconstruction","volume":"15","author":"Madjidyar J","year":"2023","unstructured":"Madjidyar J, Keller E, Winklhofer S, et al.. Single-antiplatelet regimen in ruptured cerebral blood blister and dissecting aneurysms treated with flow-diverter stent reconstruction. J Neurointerv Surg. 2023, 15:953-7. 10.1136\/jnis-2022-019361","journal-title":"J Neurointerv Surg"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000762","article-title":"Flow-diverter stents in intracranial aneurysm treatment: impact on covered cerebral artery branches","volume":"110","author":"Liu J","year":"2024","unstructured":"Liu J, Cao F, Zhenmei N, et al.. Flow-diverter stents in intracranial aneurysm treatment: impact on covered cerebral artery branches. Int J Surg. 2024, 110:53-65. 10.1097\/JS9.0000000000000762","journal-title":"Int J Surg"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144167","article-title":"Flow diversion for endovascular treatment of intracranial aneurysms: past, present, and future directions","volume":"13","author":"Gaub M","year":"2024","unstructured":"Gaub M, Murtha G, Lafuente M, et al.. Flow diversion for endovascular treatment of intracranial aneurysms: past, present, and future directions. J Clin Med. 2024, 13:10.3390\/jcm13144167","journal-title":"J Clin Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.04.009","article-title":"Safety and efficacy of flow diverter treatment for aneurysm in small cerebral vessels: a systematic review and meta-analysis","volume":"115","author":"Yan Y","year":"2018","unstructured":"Yan Y, Zhu D, Tang H, Huang Q. Safety and efficacy of flow diverter treatment for aneurysm in small cerebral vessels: a systematic review and meta-analysis. World Neurosurg. 2018, 115:54-64. 10.1016\/j.wneu.2018.04.009","journal-title":"World Neurosurg"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908077","article-title":"Ticagrelor in patients with stable coronary disease and diabetes","volume":"381","author":"Steg PG","year":"2019","unstructured":"Steg PG, Bhatt DL, Simon T, et al.. Ticagrelor in patients with stable coronary disease and diabetes. N Engl J Med. 2019, 381:1309-20. 10.1056\/NEJMoa1908077","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.032670","article-title":"Network meta-analysis of ticagrelor for stroke prevention in patients at high risk for cardiovascular or cerebrovascular events","volume":"52","author":"B\u00e1lint A","year":"2021","unstructured":"B\u00e1lint A, Tornyos D, Abdallaoui O, Kup\u00f3 P, Kom\u00f3csi A. Network meta-analysis of ticagrelor for stroke prevention in patients at high risk for cardiovascular or cerebrovascular events. Stroke. 2021, 52:2809-16. 10.1161\/STROKEAHA.120.032670","journal-title":"Stroke"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.668988","article-title":"Comparing ticagrelor versus clopidogrel in patients with a history of cerebrovascular disease: a net clinical harm?","volume":"43","author":"Dinicolantonio JJ","year":"2012","unstructured":"Dinicolantonio JJ, Serebruany VL. Comparing ticagrelor versus clopidogrel in patients with a history of cerebrovascular disease: a net clinical harm?. Stroke. 2012, 43:3409-10. 10.1161\/STROKEAHA.112.668988","journal-title":"Stroke"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/475805-single-antiplatelet-therapy-with-ticagrelor-in-flow-diversion-treatment-of-ruptured-dissecting-cerebral-pseudoaneurysms-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:23:25Z","timestamp":1774841005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/475805-single-antiplatelet-therapy-with-ticagrelor-in-flow-diversion-treatment-of-ruptured-dissecting-cerebral-pseudoaneurysms-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":56,"URL":"https:\/\/doi.org\/10.7759\/cureus.106088","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,29]]}}}